Doctor profile · Federal record
Dr. Janet Kershaw-McLennan, M.D.
Specialist · Atascadero, CA
- NPI 1215932348
- MIPS 22.4 / 100 · 2023
- 21 yrs on file
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
8105 Morro RD, Ste D
Atascadero, CA 934223911
(805) 466-7722
fax (805) 461-1763
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- August 29, 2024
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- California #G66499
- Medicaid
- CA #00G664990
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1215932348. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,222
Distinct HCPCS
8
Medicare allowed
$93,767
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
95165 |
Professional service for preparation and provision of 1 or more antigens | 761 | 37 | $16 | |
95117 |
Professional service for multiple injections of allergen | 514 | 52 | $13 | |
96372 |
Injection of drug or substance under skin or into muscle | 360 | 19 | $15 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 308 | 202 | $132 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 183 | 20 | $59 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 68 | 68 | $226 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 17 | 17 | $94 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 11 | 11 | $79 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 277. This provider delivers 8.0× the peer median.Open Payments
Industry payments received
All-time total
$1,453
Transactions
61
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 15 | $407.73 | |
| GlaxoSmithKline, LLC. | 12 | $278.17 | |
| AstraZeneca Pharmaceuticals LP | 8 | $182.14 | |
| BioCryst US Sales Co., LLC | 6 | $136.26 | |
| Regeneron Healthcare Solutions, Inc. | 5 | $110.10 | |
| CSL Behring | 3 | $75.05 | |
| Pharming Healthcare, Inc. | 3 | $64.55 | |
| Octapharma USA, Inc. | 2 | $51.95 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49.87 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.61 | |
| LEO Pharma Inc. | 1 | $20.97 | |
| Novartis Pharmaceuticals Corporation | 1 | $18.22 | |
| Amgen Inc. | 1 | $17.86 | |
| Grifols USA, LLC | 1 | $15.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
895
Patients
239
Total drug cost
$433,408
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 176 | 50 | $3,291 |
| Azelastine Hcl | Generic | 131 | 59 | $4,378 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 90 | 21 | $81,671 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 71 | 31 | $3,728 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 58 | 18 | $40,413 |
| Ipratropium Bromide | Generic | 56 | 19 | $2,554 |
| Xolair (Omalizumab) | Brand | 46 | 0 | $129,109 |
| Prednisone | Generic | 43 | 20 | $277 |
| Wixela Inhub (Fluticasone Propion/Salmeterol) | Brand | 41 | 0 | $12,622 |
| Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) | Brand | 40 | 0 | $8,068 |
Frequently asked questions
What is Dr. Janet Kershaw-McLennan's medical specialty?
Dr. Janet Kershaw-McLennan practices Specialist in Atascadero, CA.
Where does Dr. Janet Kershaw-McLennan practice?
Dr. Janet Kershaw-McLennan practices at 8105 Morro RD, Atascadero, CA 934223911. Office phone: 8054667722.
What is Dr. Janet Kershaw-McLennan's NPI?
Dr. Janet Kershaw-McLennan's National Provider Identifier (NPI) is 1215932348, issued by NPPES.
What procedures does Dr. Janet Kershaw-McLennan commonly perform?
Top Medicare-reported procedures in 2023: Professional service for preparation and provision of 1 or more antigens (HCPCS 95165); Professional service for multiple injections of allergen (HCPCS 95117); Injection of drug or substance under skin or into muscle (HCPCS 96372). Source: CMS Medicare Physician & Other Practitioners file.